Trial Profile
Double-blind, Randomised, Placebo-controlled, Multi-centre Phase II Study to Evaluate the Efficacy and Safety of Three Different Dosages of Oral Trichuris Suis Ova (TSO) Suspension in Active Crohn's Disease
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 06 Sep 2016
Price :
$35
*
At a glance
- Drugs Trichuris suis ova (Primary)
- Indications Crohn's disease
- Focus Therapeutic Use
- Acronyms TRUST-2; TRUST-II
- Sponsors Dr Falk Pharma
- 12 Nov 2013 Status changed from recruiting to discontinued, according to a Coronado Biosciences media release.
- 12 Sep 2013 Data from a second interim analysis and trial completion are expected during the fourth quarter of 2013, according to a Coronado Biosciences media release.
- 08 May 2013 Data from a second interim analysis are expected to be reported during the second half of 2013, according to a Coronado Biosciences media release.